The National Institute for Health and Care Excellence, which provides drug guidance for the NHS, said there are some side effects that can be seen commonly and include an abnormal appetite, ...
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.